Search Results 11-20 of 18837 for B cell lymphomas
... B-cell lymphoma. These include targeted therapy, immunotherapy, CAR-T cell therapy, stem cell transplantation and clinical trials. Your care team works with ...
In Burkitt lymphoma, changes happen that turn the B lymphocytes into cancer cells. The cancer cells can grow in the lymph nodes, jaw or other bones in the face, ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
Sometimes a follicular lymphomas can transform into a fast-growing lymphoma, such as diffuse large B-cell lymphoma. These lymphomas often have a worse prognosis ...
Another type of non-Hodgkin lymphoma that affects the skin is called cutaneous B-cell lymphoma. Cutaneous T-cell lymphoma is much more common than cutaneous B- ...
Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
— The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study ...
— Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.